Literature DB >> 15021915

A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis.

Sandra W Leung1, Elzbieta H Wloga, Alejandro F Castro, Thao Nguyen, Roderick T Bronson, Lili Yamasaki.   

Abstract

Rb+/- mice develop a complex spectrum of neuroendocrine tumors on a mixed genetic (129Sv x C57BL/6) background. To understand how the 129Sv and C57BL/6 contributions affect Rb+/- tumorigenesis, we serially backcrossed Rb+/- animals to the 129Sv or C57BL/6 strain, and analysed their pathological profiles. Strikingly, the length of survival and the penetrance, severity and multiplicity of neuroendocrine tumors switch dramatically between Rb+/- animals from the two genetic backgrounds. In fact, the 129Sv background significantly enhances both the initiation and progression of tumorigenesis in the intermediate lobe of the pituitary (ILP) in Rb+/- animals. This is due to the surprising fact that ILPs from wild-type 129Sv animals are inherently abnormal, and thus greatly predisposed to neoplasia. This is likely to explain the high incidence of ILP tumors, an otherwise rare tumor type in wild-type mice, in numerous knockout studies performed on the 129Sv strain, and raises the intriguing possibility that the classic Rb+/- neuroendocrine tumors may fade away in another as of yet unidentified inbred strain. Finally, we have increased the utility of the Rb+/- tumor model, since Rb+/- animals on the C57BL/6 background develop high-penetrance tumors of the anterior lobe of the pituitary, a class of tumors estimated to occur in 20-25% of humans. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021915     DOI: 10.1038/sj.onc.1207457

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Visualizing dynamic E2F-mediated repression in vivo.

Authors:  Monica Agromayor; Elzbieta Wloga; Benedetta Naglieri; John Abrashkin; Kapil Verma; Lili Yamasaki
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

2.  Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies.

Authors:  Sunita K Agarwal
Journal:  Int J Endocr Oncol       Date:  2014

Review 3.  Mouse models of endocrine tumours.

Authors:  Georgette N Jones; Parmeet K Manchanda; Daphne R Pringle; Mei Zhang; Lawrence S Kirschner
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

4.  Sca1⁺ murine pituitary adenoma cells show tumor-growth advantage.

Authors:  Ines Donangelo; Song-Guang Ren; Tamar Eigler; Clive Svendsen; Shlomo Melmed
Journal:  Endocr Relat Cancer       Date:  2014-01-30       Impact factor: 5.678

5.  Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice.

Authors:  Hongbo Wang; Frederick Bauzon; Peng Ji; Xiaoliang Xu; Daqian Sun; Joseph Locker; Rani S Sellers; Keiko Nakayama; Keiich I Nakayama; David Cobrinik; Liang Zhu
Journal:  Nat Genet       Date:  2009-12-06       Impact factor: 38.330

6.  Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Tami Rubinek; Run Yu; Anat Ben-Shlomo; Kalman Kovacs; Kolja Wawrowsky; Shlomo Melmed
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

7.  Differential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesis.

Authors:  Wei-Ming Chien; Kendra Garrison; Emily Caufield; Jason Orthel; Joshua Dill; Matthew L Fero
Journal:  Cell Cycle       Date:  2007-03-07       Impact factor: 4.534

Review 8.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

9.  The role of Cdk5 in neuroendocrine thyroid cancer.

Authors:  Karine Pozo; Emely Castro-Rivera; Chunfeng Tan; Florian Plattner; Gert Schwach; Veronika Siegl; Douglas Meyer; Ailan Guo; Justin Gundara; Gabriel Mettlach; Edmond Richer; Jonathan A Guevara; Li Ning; Anjali Gupta; Guiyang Hao; Li-Huei Tsai; Xiankai Sun; Pietro Antich; Stanley Sidhu; Bruce G Robinson; Herbert Chen; Fiemu E Nwariaku; Roswitha Pfragner; James A Richardson; James A Bibb
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

10.  Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.

Authors:  Roberto Würth; Federica Barbieri; Alessandra Pattarozzi; Germano Gaudenzi; Federico Gatto; Pietro Fiaschi; Jean-Louis Ravetti; Gianluigi Zona; Antonio Daga; Luca Persani; Diego Ferone; Giovanni Vitale; Tullio Florio
Journal:  Mol Neurobiol       Date:  2016-08-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.